USPTO serial 90617633
BELTEST IT
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LOOK, JEFFREY J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BELTEST IT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian P. Gregg
Brian P. Gregg MCNEES WALLACE & NURICK100 PINE STREETHARRISBURG, PA 17108UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Reagents for medical use; Reagents for use with analyzers for medical use; Reagents for use in diagnostic tests for medical use; Reagents for use in diagnostic pregnancy tests; Reagents for microbiological analysis for medical diagnostic use; Immunoassay reagents for medical use; Genetic identity tests comprised of reagents for medical purposes; Medical diagnostic reagents and assays for testing of body fluids; Indicators for medical diagnosis, namely, biological indicators for monitoring sterilization procedures for medical purposes; Diagnostic preparations for medical or veterinary purposes; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Enzyme preparations for veterinary purposes; Diagnostic biomarker reagents for medical purposes; Chemical preparations for testing blood for medical purposes; Diagnostic agents for medical use; Dental preparations for disclosing plaque; Medical diagnostic test strips for blood analysis, plasma analysis, serum analysis, blood component analysis, feces analysis, urine analysis, tissue analysis, tissue fluid analysis, body secretion analysis; Test strips for measuring blood glucose levels; Impregnated medicated swabs; Wadding for medical purposes; Cotton swabs for medical purposes; Swabs for medical use; Cellulose wadding for medical purposes; Tampons for medical purposes; Reagent paper for medical or veterinary purposes; Impregnated medicated wipes | ACTIVE | — |
| 010 | Indicators for medical diagnosis, namely, carbon dioxide indicators for medical use; Medical diagnostic apparatus for testing for viruses; Apparatus for analysing bacteria in biological samples for diagnostic medical use; Medical instruments for infectious disease testing; Diagnostic testing instruments for use in immunoassay procedure for medical use; Genetic testing apparatus for medical purposes; Testing apparatus for medical purposes, namely, genetic testing apparatus for medical purposes, DNA and RNA testing apparatus for medical purposes, medical diagnostic apparatus for testing blood, plasma, serum, blood components, feces, urine, tissue, tissue fluid, body secretion, blood sugar levels, cancer cells, blood toxicity levels, viral and bacterial infections; Membrane test plates for use in medical diagnostics; Medical test kits for diabetes monitoring for home use; Test probes for medical use; Medical apparatus and instruments, namely, medical radiation apparatus, medical imaging apparatus, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, electromagnetic drug delivery apparatus for medical use, medical instruments for cutting tissues, medical instruments for examining women's reproductive organs, medical instruments for use in general surgery, medical instruments for use in performing biopsies; Medical apparatus for testing the level of glucose in the blood; Apparatus for carrying-out diagnostic tests for medical purposes, namely, ultrasound diagnostic apparatus, nuclear medical diagnostic imaging apparatus, medical apparatus for diagnostic radiopharmaceutical use, organoleptic diagnostic testing apparatus; Apparatus for chromatography for medical purposes; Measuring instruments adapted for medical use, namely, blood pressure, blood flow, devices for measuring wounds, devices for measuring body position and leg movements during sleep, audiometers for measuring hearing loss, apparatus for measuring skin hydration, devices measuring tumors; Tongue depressors for medical purposes; Blood collection tubes for medical use; Medical diagnostic saliva vials; Tools for medical diagnostics, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; Medical apparatus for diagnosing suspected heart attacks; Apparatus for DNA and RNA testing for medical purposes; Electronic apparatus for medical purposes, namely, electronic medical appliances for wound healing, electronic temperature monitors, electronic muscle stimulators, EKG machines, medical apparatus for monitoring vital signs, blood property and respiratory events; Body composition analyzers for medical purposes; Automated analyzers for foreign matter contained in body fluids for medical diagnostic use; Blood group analyzers for medical use; Heat exchange anti-viral filters for medical use; Face masks for medical use for anti bacterial protection | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pharmact Holding AG
- Other trademarks owned by Pharmact Holding AG
- Other trademarks owned by Rainer Böhnke
- Other trademarks owned by Rainer Böhnke
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named BELTEST IT
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 15, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 15, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 15, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 13, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 13, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 13, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 7, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 5, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 5, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 5, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 7, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 5, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 5, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 5, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 14, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 30, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 11, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 7, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 7, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2022 | ALIE | ASSIGNED TO LIE | — |
| Mar 1, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 25, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 25, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 25, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 11, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 10, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 10, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 9, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 9, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 5, 2021 | NWAP | NEW APPLICATION ENTERED | — |